Literature DB >> 9406147

Differential nature of cross-talk among three G-coupled receptors regulating adenylyl cyclase in rat cardiomyocytes chronically exposed to receptor agonists.

P V Sulakhe1, X T Vo, R R Mainra.   

Abstract

Chronic exposure of cells to cognate agonists has been established to cause homologous desensitization of G protein-coupled receptors. In this work, we show that exposure of adult rat cardiomyocytes to isoproterenol (ISO) for 24 h led to the desensitization of beta-adrenoceptor (beta-AR) coupled adenylyl cyclase (AC) activity, which was associated with an increased inhibition of AC by M2-muscarinic receptor (MR) agonist, carbachol (Cch), and a decreased inhibition of AC by A1-adenosine receptor (AdR) agonist, N6-phenylisopropyladenosine (R-PIA). Chronic exposure of cells to Cch caused the desensitization of M2-MR-coupled AC, decreased the inhibitory action of R-PIA on AC and increased ISO-stimulated AC, while chronic exposure to R-PIA caused the desensitization of A1-AdR-coupled AC and modestly increased ISO-stimulated AC without any significant effect on Cch inhibition of the enzyme. Thus, chronic exposure of cardiomyocytes revealed for the first time a more complex and differential nature of cross-talk among the three major G-coupled receptors in modulating AC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406147

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family.

Authors:  S Katsushika; L Chen; J Kawabe; R Nilakantan; N J Halnon; C J Homcy; Y Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

3.  Isolation and characterization of a novel cardiac adenylylcyclase cDNA.

Authors:  Y Ishikawa; S Katsushika; L Chen; N J Halnon; J Kawabe; C J Homcy
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

Review 4.  Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease.

Authors:  C J Homcy; S F Vatner; D E Vatner
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

5.  Regulation of adenylyl cyclase by protein kinase A.

Authors:  G Iwami; J Kawabe; T Ebina; P J Cannon; C J Homcy; Y Ishikawa
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

Review 6.  Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases.

Authors:  R Iyengar
Journal:  FASEB J       Date:  1993-06       Impact factor: 5.191

7.  Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase.

Authors:  D A LaMonica; N Frohloff; J G Dobson
Journal:  Am J Physiol       Date:  1985-05

8.  Persistent desensitization of the heart to the inotropic action of isoproterenol by adenosine.

Authors:  W H Newman; J T Lee; J G Webb
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-11

Review 9.  Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.

Authors:  P V Sulakhe; X T Vo
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

10.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

View more
  1 in total

1.  EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.

Authors:  Leanne P Kelley-Hickie; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.